跳至主要内容
临床试验/NCT07405294
NCT07405294进行中(未招募)不适用

A Retrospective Cohort Study Comparing Clinical Outcomes and Unscheduled Follow-up of Telemedicine and In-person Medication Abortion

Columbia University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2023年6月12日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
400
试验地点
1
主要终点
Number of unscheduled follow-ups

研究概览

简要总结

The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.

详细描述

This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
  • Gestational age <70 days (based on best obstetrical dating)
  • English or Spanish speaking

排除标准

  • Received mifepristone and misoprostol for early pregnancy loss
  • Patient determined to have contraindication to medication abortion
  • Opted for procedural management instead of medication abortion
  • Decided to continue with the pregnancy
  • Presenting for a second medication abortion at CUIMC during the study period
  • Non-English or Spanish speaking

研究组 & 干预措施

Telemedicine Med Ab

Patients who received medication abortion through the telemedicine medication abortion service during the study period.

干预措施: Telemedicine Medication Abortion (Other)

In-person Med Ab

Patients who received an in-person medication abortion at the clinic during the study period.

结局指标

主要结局

Number of unscheduled follow-ups

时间窗: 3 months after initial encounter

If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erika Levi, MD

Wyeth-Ayerst Associate Professor of Women's Health in Obstetrics and Gynecology

Columbia University

研究点 (1)

Loading locations...

相似试验